Karim Boudadi
Oncology | Hematology Oncology | Otolaryngology
6420 Rockledge Drive
Suite 4950
Bethesda, MD 20817
Suite 4950
Bethesda, MD 20817
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Implementation of a Novel Subspecialty Outpatient Palliative Medicine Head and Neck Cancer Clinic.
Journal: The Laryngoscope
Published: June 14, 2026
ICI-induced Granulomatous Sialadenitis is Responsive to Prednisone.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
ICI-induced Granulomatous Sialadenitis is Responsive to Prednisone.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
Discovery of Methylated DNA Biomarkers for Potential Nonendoscopic Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
Journal: The American journal of gastroenterology
Published: August 13, 2024
Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
Journal: Radiation oncology (London, England)
Published: February 09, 2024
Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures.
Journal: Journal for immunotherapy of cancer
Published: April 18, 2021
Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial.
Journal: The Prostate
Published: November 17, 2020
The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma.
Journal: Oral oncology
Published: July 22, 2020
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.
Journal: Oncotarget
Published: April 19, 2018
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer.
Journal: Cancer chemotherapy and pharmacology
Published: October 31, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis.
Journal: Prostate cancer and prostatic diseases
Published: June 15, 2016
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical Medicine Insights. Oncology
Published: December 22, 2015
Last Updated: 09/26/2026